4893 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Noile-Immune Biotech, Inc. is a biotech company. It engages in the development of CAR-T cell therapy, a cancer immunotherapy for solid tumors using proprietary technology. The company was founded on April 16, 2015 and is headquartered in Tokyo, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
4893 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company